Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8759211 | 0.86 | ALDH1A1 (0.50) | ALDH1A1TSHRTHRB | |
| SCHEMBL22247 | 0.82 | — | — | |
| SCHEMBL19970453 | 0.82 | ALDH1A1 (0.60) | ALDH1A1TSHRTHRB | |
| SCHEMBL2353242 | 0.80 | — | — | |
| SCHEMBL16329684 | 0.79 | ALDH1A1 (0.35) | ALDH1A1TSHR | |
| SCHEMBL9639226 | 0.78 | ALDH1A1 (0.56) | ALDH1A1TSHRTHRB | |
| SCHEMBL989839 | 0.78 | ALDH1A1 (0.56) | ALDH1A1TSHRTHRB | |
| SCHEMBL5839297 | 0.78 | ALDH1A1 (0.56) | ALDH1A1TSHRTHRB | |
| SCHEMBL987828 | 0.78 | ALDH1A1 (0.56) | ALDH1A1TSHRTHRB | |
| SCHEMBL1204192 | 0.78 | ALDH1A1 (0.56) | ALDH1A1TSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119241448-A | Pharmaceutically acceptable salts and crystals of tyrosine kinase inhibitor, preparation method and application thereof | 安润医药科技（苏州）有限公司 | 2025-01-03 | — | — | CN | claimed |
| US-4088536-A | ALKYLATING LITHIUM CYCLOPENTADIENE, OXYGENATING TO PRODUCE HYDROXYCLYCLOPENTENONES, SEPARATION, MULTISTAGE | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1978-05-09 | — | — | US | claimed |
| CN-120757509-A | Pharmaceutically acceptable salts and crystals of tyrosine kinase inhibitor, preparation method and application thereof | 安润医药科技（苏州）有限公司 | 2025-10-10 | — | — | CN | disclosed |
| CN-119241448-A | Pharmaceutically acceptable salts and crystals of tyrosine kinase inhibitor, preparation method and application thereof | 安润医药科技（苏州）有限公司 | 2025-01-03 | — | — | CN | disclosed |
| CN-119241448-A | Pharmaceutically acceptable salts and crystals of tyrosine kinase inhibitor, preparation method and application thereof | 安润医药科技（苏州）有限公司 | 2025-01-03 | — | — | CN | disclosed |
| EP-0823908-B1 | PYRIDO[2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION | WARNER LAMBERT CO (US) | 2006-11-02 | — | — | EP | disclosed |
| US-5733914-A | Pyrido 2, 3-d!pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation | WARNER-LAMBERT COMPANY (US) | 1998-03-31 | — | — | US | disclosed |
| EP-0823908-A1 | PYRIDO 2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION | WARNER-LAMBERT COMPANY (US) | 1998-02-18 | — | — | EP | disclosed |
| EP-0664281-B1 | ISOCARBACYCLIN WITH MODIFIED alpha(a)-CHAIN AND PROCESS FOR PRODUCING THE SAME | TEIJIN LTD (JP) | 1997-05-28 | — | — | EP | disclosed |
| US-5620981-A | ANTICARCINOGENIC AGENTS, ATHEROSCLEROSIS, RESTENOSIS, PSORIASIS | WARNER-LAMBERT COMPANY (US) | 1997-04-15 | — | — | US | disclosed |
| WO-1996034867-A1 | PYRIDO[2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION | WARNER-LAMBERT COMPANY (US) | 1996-11-07 | — | — | WO | disclosed |
| EP-0664281-A1 | ISOCARBACYCLIN WITH MODIFIED $g(a)-CHAIN AND PROCESS FOR PRODUCING THE SAME | TEIJIN LIMITED (JP) | 1995-07-26 | — | — | EP | disclosed |
| EP-0043479-A1 | Novel cyclopentenone derivatives and methods for the preparation of the novel compounds | AMERICAN CYANAMID COMPANY (US) | 1982-01-13 | — | — | EP | disclosed |
| EP-0013107-A1 | 16-Hydroxy-16-vinyl (or cyclopropyl)-prostan-1-ols and pharmaceutical compositions containing the same | AMERICAN CYANAMID COMPANY (US) | 1980-07-09 | — | — | EP | disclosed |
| US-4206151-A | BRONCHODILATOR, ANTISECRETORY, HYPOTENSIVE | AMERICAN CYANAMID COMPANY (US) | 1980-06-03 | — | — | US | disclosed |
| US-4142056-A | MULTISTAGE PROCESS FOR PREPARING 2-(6'-CARBOMETHOXYHEXYL)-2-CYCLOPENTEN-1-ONE | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1979-02-27 | — | — | US | disclosed |
| US-4088536-A | ALKYLATING LITHIUM CYCLOPENTADIENE, OXYGENATING TO PRODUCE HYDROXYCLYCLOPENTENONES, SEPARATION, MULTISTAGE | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1978-05-09 | — | — | US | disclosed |
| US-4031129-A | LITHIUM CYCLOPENTADIENE, ETHYL-7-BROMOHEPTANOATE | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1977-06-21 | — | — | US | disclosed |